Pro-inflammatory cytokines are associated with the development of post-stroke depression in the acute stage of stroke: A meta-analysis

References

• Roth M. The natural history of mental disorder in old age. J Ment Sci. 1955;101(423):281–301. doi:10.1192/bjp.101.423.281.
   PubMed Web of Science ®Google Scholar
• Hackett ML, Pickles K. Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke. 2014;9(8):1017–1025. doi:10.1111/ijs.12357.
   PubMed Web of Science ®Google Scholar
• Robinson RG, Jorge RE. Post-Stroke Depression: A Review. Am J Psychiatry. 2016;173(3):221–231. doi:10.1176/appi.ajp.2015.15030363.
   PubMed Web of Science ®Google Scholar
• Hung JW, Huang YC, Chen JH, et al. Factors associated with strain in informal caregivers of stroke patients. Chang Gung Med J. 2012;5(5):392–401.doi:10.4103/2319-4170.105479.
   Google Scholar
• Chen Y, Patel NC, Guo JJ, Zhan S. Antidepressant prophylaxis for poststroke depression: a meta-analysis. Int Clin Psychopharmacol. 2007;22(3):159–166. doi:10.1097/YIC.0b013e32807fb028.
   PubMed Web of Science ®Google Scholar
• Kim JM, Stewart R, Bae KY, et al. Serotonergic and BDNF genes and risk of depression after stroke. J Affect Disord. 2012;136(3):833–840.doi:10.1016/j.jad.2011.09.029.
   PubMed Web of Science ®Google Scholar
• Salter KL, Foley NC, Zhu L, Jutai JW, Teasell RW. Prevention of poststroke depression: does prophylactic pharmacotherapy work? J Stroke Cerebrovasc Dis. 2013;22(8):1243–1251. doi:10.1016/j.jstrokecerebrovasdis.2012.03.013.
   PubMed Web of Science ®Google Scholar
• FOCUS Trial Collaboration. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet. 2019;393:(10168):265–274. doi:10.1016/S0140-6736(18)32823-X.
   PubMed Web of Science ®Google Scholar
• Acler M, Robol E, Fiaschi A, Manganotti P. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol. 2009;256(7):1152–1158. doi:10.1007/s00415-009-5093-7.
   PubMed Web of Science ®Google Scholar
• Villa RF, Ferrari F, Moretti A. Post-stroke depression: mechanisms and pharmacological treatment. Pharmacol Ther. 2018;184:131–144. doi:10.1016/j.pharmthera.2017.11.005.
   PubMed Web of Science ®Google Scholar
• Meader N, Moe-Byrne T, Llewellyn A, Mitchel AJ. Screening for poststroke major depression: a meta-analysis of diagnostic validity studies. J Neurol Neurosurg Psychiatry. 2014;85(2):198–206. doi:10.1136/jnnp-2012-304194.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Proinflammatory cytokines. Chest. 2000;118(2):503–508. doi:10.1378/chest.118.2.503.
   PubMed Web of Science ®Google Scholar
• Stenken JA, Poschenrieder AJ. Bioanalytical chemistry of cytokines–a review. Anal Chim Acta. 2015;853:95–115. doi:10.1016/j.aca.2014.10.009.
   PubMed Web of Science ®Google Scholar
• Kubera M, Holan V, Mathison R, Maes M. The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology. 2000;25(8):785–797. doi:10.1016/s0306-4530(00)00026-3.
   PubMed Web of Science ®Google Scholar
• Walker FR. A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology. 2013;67:304–317. doi:10.1016/j.neuropharm.2012.10.002.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457.doi:10.1016/j.biopsych.2009.09.033.
   PubMed Web of Science ®Google Scholar
• Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab. 2012;32(9):1677–1698. doi:10.1038/jcbfm.2012.88.
   PubMed Web of Science ®Google Scholar
• Levada OA, Troyan AS. Poststroke Depression Biomarkers: A Narrative Review. Front Neurol. 2018;9:577. doi:10.3389/fneur.2018.00577.
   PubMed Web of Science ®Google Scholar
• Spalletta G, Bossù P, Ciaramella A, Bria P, Caltagirone C, Robinson RG. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry. 2006;11(11):984–991. doi:10.1038/sj.mp.4001879.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi:10.1136/bmj.b2700.
   PubMed Web of Science ®Google Scholar
• Pu J, Yu Y, Liu Y, et al. MENDA: a comprehensive curated resource of metabolic characterization in depression. Brief Bioinform. 2019. doi:10.1093/bib/bbz055.
   PubMed Web of Science ®Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. doi:10.1186/1471-2288-5-13.
   PubMedGoogle Scholar
• Wells G, Shea B, O’Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute web site. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed May 24, 2017.
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188. doi:10.1016/0197-2456(86)90046-2.
   PubMedGoogle Scholar
• Noonan K, Carey LM, Crewther SG. Meta-analyses indicate associations between neuroendocrine activation, deactivation in neurotrophic and neuroimaging markers in depression after stroke. J Stroke Cerebrovasc Dis. 2013;22(7):e124–35. doi:10.1016/j.jstrokecerebrovasdis.2012.09.008.
   PubMed Web of Science ®Google Scholar
• Whiteley W, Jackson C, Lewis S, et al. Inflammatory markers and poor outcome after stroke: a prospective cohort studyand systematic review of interleukin-6. PLoS Med. 2009;6(9):e1000145.doi:10.1371/journal.pmed.1000145.
   PubMed Web of Science ®Google Scholar
• Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008;37(5):1148–1157. doi:10.1093/ije/dyn065.
   PubMed Web of Science ®Google Scholar
• Cai W, Stewart R, Mueller C, Li YJ, Shen WD. Poststroke depression and risk of stroke recurrence and mortality: protocol of a meta-analysis and systematic review. BMJ Open. 2018;8(12):e026316. doi:10.1136/bmjopen-2018-026316.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi:10.1136/bmj.315.7109.629.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–463. doi:10.1111/j.0006-341x.2000.00455.x.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhu Z, Liu Y, Tu X, He J. Relationship between serum vitamin D levels and inflammatory markers in acute stroke patients. Brain Behav. 2018;8(2):e00885. doi:10.1002/brb3.885.
   PubMed Web of Science ®Google Scholar
• Spalletta G, Cravello L, Imperiale F,, et al. Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J Neuropsychiatry Clin Neurosci. 2013;25(4):255–263.doi:10.1176/appi.neuropsych.12120399.
   PubMed Web of Science ®Google Scholar
• Kang HJ, Bae KY, Kim SW. et al. Effects of interleukin-6, interleukin-18, and statin use, evaluated at acute stroke, on post-stroke depression during 1-year follow-up. Psychoneuroendocrinology. 2016;72:156–160. doi:10.1016/j.psyneuen.2016.07.001.
   PubMed Web of Science ®Google Scholar
• Meng G, Ma X, Li L, et al. Predictors of early-onset post-ischemic stroke depression: a cross-sectional study. BMC Neurol. 2017;17(1):199.doi:10.1186/s12883-017-0980-5.
   PubMedGoogle Scholar
• Mu Y, Wang Z, Zhou J, Tan C, Wang H. Correlations of Post-stroke Depression with Inflammatory Response Factors. Iran J Public Health. 2018;47:988–993.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang Z, Sun D, Xu Z, Zhang X, Li L. The serum interleukin-18 is a potential marker for development of post-stroke depression. Neurol Res. 2010;32(4):340–346. doi:10.1179/016164110x12656393665080.
   PubMed Web of Science ®Google Scholar
• Zhang XF, Zou W, Yang Y. Effects of IL-6 and cortisol fluctuations in post-stroke depression. J Huazhong Univ Sci Technol Med Sci. 2016;36(5):732–735. doi:10.1007/s11596-016-1653-0.
   PubMedGoogle Scholar
• Kim JM, Kang HJ, Kim JW, et al. Associations of Tumor Necrosis Factor-α and Interleukin-1β Levels and Polymorphisms with Post-Stroke Depression. Am J Geriatr Psychiatry. 2017;25(12):1300–1308.doi:10.1016/j.jagp.2017.07.012.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56. doi:10.1038/nrn2297.
   PubMed Web of Science ®Google Scholar
• Yirmiya R, Rimmerman N, Reshef R. Depression as a microglial disease. Trends Neurosci. 2015;38(10):637–658. doi:10.1016/j.tins.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory Disequilibrium in Stroke. Circ Res. 2016;119(1):142–158. doi:10.1161/circresaha.116.308022.
   PubMed Web of Science ®Google Scholar
• Köhler CA, Freitas TH, Maes M, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135(5):373–387.doi:10.1111/acps.12698.
   PubMed Web of Science ®Google Scholar
• Shi K, Tian DC, Li ZG, et al. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058–1066.doi:10.1016/s1474-4422(19)30078-x.
   PubMed Web of Science ®Google Scholar
• Perini F, Morra M, Alecci M, et al. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci. 2001;22(4):289–296.doi:10.1007/s10072-001-8170-y.
   PubMed Web of Science ®Google Scholar
• Zaremba J, Losy J. Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand. 2001;104(5):288–295. doi:10.1034/j.1600-0404.2001.00053.x.
   PubMed Web of Science ®Google Scholar
• Chen CY, Chen CL, Yang YH, Ho CH, Tseng WC. Poststroke Depressive Symptoms Are Associated With Increased Oxidative Deoxyribonucleic Acid Damage. J Neuropsychiatry Clin Neurosci. 2018;30(2):139–144. doi:10.1176/appi.neuropsych.17050108.
   PubMed Web of Science ®Google Scholar
• Ormstad H, Aass HC, Amthor KF, Lund-Sørensen N, Sandvik L. Serum levels of cytokines, glucose, and hemoglobin as possible predictors of poststroke depression, and association with poststroke fatigue. Int J Neurosci. 2012;122(11):682–690. doi:10.3109/00207454.2012.709892.
   PubMed Web of Science ®Google Scholar
• Ormstad H, Aass HC, Lund-Sørensen N, Amthor KF, Sandvik L. Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol. 2011;258(4):677–685. doi:10.1007/s00415-011-6006-0.
   PubMed Web of Science ®Google Scholar
• Pu J, Liu Y, Zhang H, et al. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry. 2020. doi:10.1038/s41380-020-0645-4.
   PubMed Web of Science ®Google Scholar
• Fassbender K, Rossol S, Kammer T, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci. 1994;122(2):135–139.doi:10.1016/0022-510x(94)90289-5.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med. 2004;23(11):1663–1682. doi:10.1002/sim.1752.
   PubMed Web of Science ®Google Scholar